Navigation Links
Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue
Date:2/14/2008

Three months ended Twelve months ended

Dec 31 Dec 31 Dec 31 Dec 31

2007 2006 2007 2006 REVENUE $5,891,412 $5,797,012 $24,568,824 $23,425,090 COST OF REVENUE 2,496,674 2,397,481 9,892,226 9,369,257

Gross profit 3,394,738 3,399,531 14,676,598 14,055,833 OPERATING EXPENSES:

General and

administrative 978,962 812,431 3,948,642 3,278,826

Marketing and selling 822,833 682,328 3,099,909 2,769,310

Research and

development 111,526 103,870 489,007 444,532

1,913,321 1,598,629 7,537,558 6,492,668

Income from

operations 1,481,417 1,800,902 7,139,040 7,563,165

Interest income 114,600 94,061 416,647 294,036

INCOME BEFORE PROVISION

FOR INCOME TAXES 1,596,017 1,894,963 7,555,687 7,857,201

PROVISION FOR INCOME

TAXES 689,200 719,000 3,072,000 2,955,000

NET INCOME $906,817 $1,175,963 $4,483,687 $4,902,201

BASIC NET INCOME

PER SHARE $0.17 $0.23 $0.86 $0.95

DILUTED NET INCOME

PER SHARE $0.17 $0.22 $0.85 $0.94

DIVIDENDS DECLARED

PER SHARE $0.15 $0.125 $0.60 $ 0.475

WEIGHTED AVERAGE COMMON

SHARES OUTSTANDING,

BASIC 5,220,326 5,172,247 5,205,032 5,170,258

WEIGHTED AVERAGE COMMON

SHARES OUTSTANDING,

DILUTED 5,303,474 5,248,503 5,301,620 5,240,155

PSYCHEMEDICS CORPORATION


'/>"/>

SOURCE Psychemedics Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
2. Jennifer Chmieleski Joins Psychemedics Corporation as Top Financial Officer
3. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
4. Brooke Franchise Corporation Announces Selected July Results
5. MedThink Communications Retained by NanoBio Corporation
6. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
7. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
8. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
9. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
10. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
11. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...be held on January 8, 2009 , , TORONTO, Nov...nal Inc. ("MedEmerg") (OTCBB: MDER), one of Canada... today that it has obtained an interim order from ...ts previously announced plan of arrangement (the "...nc. ("AIM") will acquire all of MedEmerg,s outstan...
(Date:11/21/2008)...ty of Texas Health Science Center at Houston will ... Studies (TEXAS), to promote geriatrics training f...rd from the Donald W. Reynolds Foundation and $1.2... to teach geriatric medicine principles to everyon...ng physicians. With the reach of Lyndon B. Johnson...
(Date:11/21/2008)...e-FirstCall/ -- Heska Corporation,(Nasdaq: HSKA... Society of,Security Analysts, 12th Annual Biotec...2008 at 1177 Avenue of the Americas, 2nd Floor in ...gin at 9:35 a.m. Eastern Time (7:35 a.m.,Mountain...for two weeks,following the presentation through ...
(Date:11/21/2008)...-USNewswire/ -- The Generic,Pharmaceutical Associ...y from,GPhA President and CEO Kathleen Jaeger reg...ble on "Emerging Health Care Competition and Consu...is conducting this roundtable demonstrates the,gr... access to safe and,affordable biogenerics sooner...
Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:GPhA Statement on FTC Roundtable on Biogenerics 2
...done in Greece to show the relationship of the pla...some interesting results.// The study took into co...plains and those living in the hills, data taken i... years, especially concerned with coronary disease...
...nity may lead you to blindness. According to a new...//scientists had been able to find out a genetic c...h of what is commonly known as blindness due to ag... that may cause macular degeneration in elderly pe...
...been successful in developing a computer aided ale...is in patients. //There had not been much attempts...t innovation is one of the first of its kind. The ...tion may be able to reduce the frequency of the co...
... that the drug Rimonabant (Acomplia) a selective ... patients keep weight off // . Supplementation wit...significant decrease in body weight and waist circ...us visceral fat. It also improved HDL (good) chole...
Other Medicine News:
(Date:11/20/2008)... RESULTS OF FIRST PHASE III TRIAL SHOW SIGNIFICANT...ENT IN DAILY FUNCTION, IN, ...., and BRUSSELS, Belgium, Nov. 20 /PRNewswire-Firs...AZZ ) and UCB (Euronext Brussels: UCB),announced ...he first of two,Phase III pivotal clinical trials...
(Date:11/20/2008)...0 Duska Therapeutics,I...hat it has submitted its,pivotal Phase 3 ATPace c...,Protocol Assessment (SPA) procedure with the U.S....ject to securing an agreement with the FDA, Duska ...-blind, placebo-controlled and randomized Phase 3,...
(Date:11/20/2008)...mber 20 The Scandinavian-based dru...ed results of studies on its,lead antimicrobial c..., DC,the studies showed that the novel lytic pep...ct, significantly better towards killing Staphyloc...eted gold standard drugs. In,addition to this it ...
(Date:11/19/2008)...rt basic findings on critical enzyme,s regulation ...an array of disorders , , MEMPHIS, Tenn., N...t. Jude Children,s Research Hospital have gained n...nzyme workhorses called calpains. , , As t...on in many cellular processes, including the movem...
Breaking Medicine Technology:Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Buyer of Bayonne Hospital to Pay U S 242 5 Million to Resolve Allegations of Medicare Fraud 10950 1Buyer of Bayonne Hospital to Pay U S 242 5 Million to Resolve Allegations of Medicare Fraud 10950 2Public Health Woefully Underfunded in Administrations Proposed Budget 10948 1Public Health Woefully Underfunded in Administrations Proposed Budget 10948 2Public Health Woefully Underfunded in Administrations Proposed Budget 10948 3Organ Donor Shortage Remains Obstacle for Would Be Transplant Patients Despite Better Medicine 1312 1Organ Donor Shortage Remains Obstacle for Would Be Transplant Patients Despite Better Medicine 1312 2Formerly Conjoined Twins Leave Packard Childrens Hospital 3B Heading Home to Costa Rica 10945 1Formerly Conjoined Twins Leave Packard Childrens Hospital 3B Heading Home to Costa Rica 10945 2
Used for contralateral access to the iliac artery for interventional procedures after initial wire guide positioning has been established.,NOTE: Use of a heavy-duty wire guide is recommended.
Sheath Introducers with guidewires.
The Driver Stent design, utilizing an advanced cobalt-based alloy, surpasses the limitations of stainless steel stents. This stronger alloy makes possible thinner struts, for unparalleled flexibility
The complete performance package. Precision handling. Stable platform for device delivery. Enhanced backup support. Unique braid technology. Improved curve retention. Smooth PTFE liner.
Medicine Products: